Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 7/2011

01.10.2011 | Original Paper

Is personal and social functioning associated with subjective quality of life in schizophrenia patients living in the community?

verfasst von: Sofia Brissos, Vicent Balanzá-Martinez, Vasco Videira Dias, Ana Isabel Carita, Maria Luisa Figueira

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 7/2011

Einloggen, um Zugang zu erhalten

Abstract

Subjective quality of life (QoL) and psychosocial functioning constitute important treatment outcomes in schizophrenia. We aimed to investigate the relationship between them in schizophrenia patients living in the community. Symptom severity and insight were assessed with the Positive and Negative Syndrome Scale (PANSS) in 76 community schizophrenia patients. Social functioning was measured with the Portuguese version of Personal and Social Performance (PSP) scale, and subjective QoL was measured with the Portuguese version of the WHO Quality of Life Measure–Abbreviated Version (WHOQOL–Bref). The majority of patients were single (78%) and unemployed/inactive (74%). Mean PSP total score was 55.5, and mean scores on WHOQOL-Bref domains ranged from 54.1 to 63.0. Greater symptom severity and worse insight were significantly associated with worse functioning in all PSP domains. Symptoms were more moderately correlated with QoL, with no significant correlations between QoL and positive symptoms and insight levels. Partial correlations controlling for symptom severity revealed no significant associations between social functioning and subjective QoL. Symptom severity may exert a greater influence on social functioning than on subjective QoL; however, social functioning was not associated with subjective QoL. The results suggest these constructs might be independent and should be assessed separately. A broader research approach, with increased attention to social and psychological factors, may help identify treatment targets to improve schizophrenia patients’ social functioning and QoL.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Juckel G, Morosini PL (2008) The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia. Curr Opin Psychiatry 21:630–639PubMedCrossRef Juckel G, Morosini PL (2008) The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia. Curr Opin Psychiatry 21:630–639PubMedCrossRef
3.
Zurück zum Zitat Figueira ML, Brissos S (2011) Measuring psychosocial outcomes in schizophrenia patients. Curr Opin Psychiatry 44:91–99 Figueira ML, Brissos S (2011) Measuring psychosocial outcomes in schizophrenia patients. Curr Opin Psychiatry 44:91–99
4.
Zurück zum Zitat Group WHOQOL (1995) The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 41:1403–1409CrossRef Group WHOQOL (1995) The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 41:1403–1409CrossRef
5.
Zurück zum Zitat Harvey PD, Velligan DI, Bellack AS (2007) Performance-based measures of functional skills: usefulness in clinical treatment studies. Schizophr Bull 33:1138–1148PubMedCrossRef Harvey PD, Velligan DI, Bellack AS (2007) Performance-based measures of functional skills: usefulness in clinical treatment studies. Schizophr Bull 33:1138–1148PubMedCrossRef
6.
Zurück zum Zitat Yamauchi K, Aki H, Tomotake M, Iga J, Numata S, Motoki I, Izaki Y, Tayoshi S, Kinouchi S, Sumitani S, Tayoshi S, Takikawa Y, Kaneda Y, Taniguchi T, Ishimoto Y, Ueno S, Ohmori T (2008) Predictors of subjective and objective quality of life in outpatients with schizophrenia. Psychiatry Clin Neurosci 62:404–411PubMedCrossRef Yamauchi K, Aki H, Tomotake M, Iga J, Numata S, Motoki I, Izaki Y, Tayoshi S, Kinouchi S, Sumitani S, Tayoshi S, Takikawa Y, Kaneda Y, Taniguchi T, Ishimoto Y, Ueno S, Ohmori T (2008) Predictors of subjective and objective quality of life in outpatients with schizophrenia. Psychiatry Clin Neurosci 62:404–411PubMedCrossRef
7.
Zurück zum Zitat Voruganti L, Heslegrave R, Awad AG, Seeman MV (1998) Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol Med 28:165–172PubMedCrossRef Voruganti L, Heslegrave R, Awad AG, Seeman MV (1998) Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol Med 28:165–172PubMedCrossRef
8.
Zurück zum Zitat Becchi A, Rucci P, Placentino A, Neri G, de Girolamo G (2004) Quality of life in patients with schizophrenia–comparison of self-report and proxy assessments. Soc Psychiatry Psychiatr Epidemiol 39:397–401PubMedCrossRef Becchi A, Rucci P, Placentino A, Neri G, de Girolamo G (2004) Quality of life in patients with schizophrenia–comparison of self-report and proxy assessments. Soc Psychiatry Psychiatr Epidemiol 39:397–401PubMedCrossRef
9.
Zurück zum Zitat Burns T, Patrick D (2007) Social functioning as an outcome measure in schizophrenia studies. Acta Psychiatr Scand 16:403–418CrossRef Burns T, Patrick D (2007) Social functioning as an outcome measure in schizophrenia studies. Acta Psychiatr Scand 16:403–418CrossRef
10.
Zurück zum Zitat Apiquian R, Elena Ulloa R, Herrera-Estrella M, Moreno-Gómez A, Erosa S, Contreras V, Nicolini H (2009) Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia. Schizophr Res 112:181–186PubMedCrossRef Apiquian R, Elena Ulloa R, Herrera-Estrella M, Moreno-Gómez A, Erosa S, Contreras V, Nicolini H (2009) Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia. Schizophr Res 112:181–186PubMedCrossRef
11.
Zurück zum Zitat Möller HJ, Jäger M, Riedel M, Obermeier M, Strauss A, Bottlender R (2010) The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity. Eur Arch Psychiatry Clin Neurosci 260:367–384PubMedCrossRef Möller HJ, Jäger M, Riedel M, Obermeier M, Strauss A, Bottlender R (2010) The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity. Eur Arch Psychiatry Clin Neurosci 260:367–384PubMedCrossRef
12.
Zurück zum Zitat Bowie CR, Reichenberg A, Patterson TL, Heaton RK, Harvey PD (2006) Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry 163:418–425PubMedCrossRef Bowie CR, Reichenberg A, Patterson TL, Heaton RK, Harvey PD (2006) Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry 163:418–425PubMedCrossRef
13.
Zurück zum Zitat Milev P, Ho BC, Arndt S, Andreasen NC (2005) Preditive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 162:495–506PubMedCrossRef Milev P, Ho BC, Arndt S, Andreasen NC (2005) Preditive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 162:495–506PubMedCrossRef
14.
Zurück zum Zitat Velligan DI, Alphs L, Lancaster S, Morlock R, Mintz J (2009) Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophrenia. Psychiatry Res 169:97–100PubMedCrossRef Velligan DI, Alphs L, Lancaster S, Morlock R, Mintz J (2009) Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophrenia. Psychiatry Res 169:97–100PubMedCrossRef
15.
Zurück zum Zitat Hofer A, Kemmler G, Eder U, Edlinger M, Hummer M, Fleischhacker WW (2004) Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects. J Clin Psychiatry 65:932–939PubMedCrossRef Hofer A, Kemmler G, Eder U, Edlinger M, Hummer M, Fleischhacker WW (2004) Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects. J Clin Psychiatry 65:932–939PubMedCrossRef
16.
Zurück zum Zitat Ruggeri M, Nosè M, Bonetto C, Cristofalo D, Lasalvia A, Salvi G, Stefani B, Malchiodi F, Tansella M (2005) Changes and predictors of change in objective and subjective quality of life: multiwave follow-up study in community psychiatric practice. Br J Psychiatry 187:121–130PubMedCrossRef Ruggeri M, Nosè M, Bonetto C, Cristofalo D, Lasalvia A, Salvi G, Stefani B, Malchiodi F, Tansella M (2005) Changes and predictors of change in objective and subjective quality of life: multiwave follow-up study in community psychiatric practice. Br J Psychiatry 187:121–130PubMedCrossRef
17.
Zurück zum Zitat Norman RM, Malla AK, McLean T, Voruganti LP, Cortese L, McIntosh E, Cheng S, Rickwood A (2000) The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale. Acta Psychiatr Scand 102:303–309PubMedCrossRef Norman RM, Malla AK, McLean T, Voruganti LP, Cortese L, McIntosh E, Cheng S, Rickwood A (2000) The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale. Acta Psychiatr Scand 102:303–309PubMedCrossRef
18.
Zurück zum Zitat Dickerson FB, Ringel NB, Parente F (1998) Subjective quality of life in out-patients with schizophrenia: clinical and utilization correlates. Acta Psychiatr Scand 98:124–127PubMedCrossRef Dickerson FB, Ringel NB, Parente F (1998) Subjective quality of life in out-patients with schizophrenia: clinical and utilization correlates. Acta Psychiatr Scand 98:124–127PubMedCrossRef
19.
Zurück zum Zitat Fitzgerald PB, Williams CL, Corteling N, Filia SL, Brewer K, Adams A, de Castella AR, Rolfe T, Davey P, Kulkarni J (2001) Subject and observer-rated quality of life in schizophrenia. Acta Psychiatr Scand 103:387–392PubMedCrossRef Fitzgerald PB, Williams CL, Corteling N, Filia SL, Brewer K, Adams A, de Castella AR, Rolfe T, Davey P, Kulkarni J (2001) Subject and observer-rated quality of life in schizophrenia. Acta Psychiatr Scand 103:387–392PubMedCrossRef
20.
Zurück zum Zitat Reine G, Lançon C, Di Tucci S, Sapin C, Auquier P (2003) Depression and subjective quality of life in chronic phase schizophrenic patients. Acta Psychiatr Scand 108:297–303PubMedCrossRef Reine G, Lançon C, Di Tucci S, Sapin C, Auquier P (2003) Depression and subjective quality of life in chronic phase schizophrenic patients. Acta Psychiatr Scand 108:297–303PubMedCrossRef
21.
Zurück zum Zitat Aki H, Tomotake M, Kaneda Y, Iga J, Kinouchi S, Shibuya-Tayoshi S, Tayoshi SY, Motoki I, Moriguchi K, Sumitani S, Yamauchi K, Taniguchi T, Ishimoto Y, Ueno S, Ohmori T (2008) Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia. Psychiatry Res 158:19–25PubMedCrossRef Aki H, Tomotake M, Kaneda Y, Iga J, Kinouchi S, Shibuya-Tayoshi S, Tayoshi SY, Motoki I, Moriguchi K, Sumitani S, Yamauchi K, Taniguchi T, Ishimoto Y, Ueno S, Ohmori T (2008) Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia. Psychiatry Res 158:19–25PubMedCrossRef
22.
Zurück zum Zitat Narvaez JM, Twamley EW, McKibbin CL, Heaton RK, Patterson TL (2008) Subjective and objective quality of life in schizophrenia. Schizophr Res 98:201–208PubMedCrossRef Narvaez JM, Twamley EW, McKibbin CL, Heaton RK, Patterson TL (2008) Subjective and objective quality of life in schizophrenia. Schizophr Res 98:201–208PubMedCrossRef
23.
Zurück zum Zitat Priebe S, Katsakou C, Yeeles K, Amos T, Morriss R, Wang D, Wykes T (2010) Predictors of clinical and social outcomes following involuntary hospital admission: a prospective observational study. Eur Arch Psychiatry Clin Neurosci [Epub ahead of print] Priebe S, Katsakou C, Yeeles K, Amos T, Morriss R, Wang D, Wykes T (2010) Predictors of clinical and social outcomes following involuntary hospital admission: a prospective observational study. Eur Arch Psychiatry Clin Neurosci [Epub ahead of print]
24.
Zurück zum Zitat Awad AG (1992) Quality of life of schizophrenic patients on medications and implications for new drug trials. Hosp Community Psychiatry 43:262–265PubMed Awad AG (1992) Quality of life of schizophrenic patients on medications and implications for new drug trials. Hosp Community Psychiatry 43:262–265PubMed
25.
Zurück zum Zitat Brissos S, Dias VV, Carita AI, Martinez-Arán A (2008) Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates. Psychiatry Res 160:55–62PubMedCrossRef Brissos S, Dias VV, Carita AI, Martinez-Arán A (2008) Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates. Psychiatry Res 160:55–62PubMedCrossRef
26.
Zurück zum Zitat Savilla K, Kettler L, Galletly C (2008) Relationships between cognitive deficits, symptoms and quality of life in schizophrenia. Aust N Z J Psychiatry 42:496–504PubMedCrossRef Savilla K, Kettler L, Galletly C (2008) Relationships between cognitive deficits, symptoms and quality of life in schizophrenia. Aust N Z J Psychiatry 42:496–504PubMedCrossRef
27.
Zurück zum Zitat Melle I, Røssberg JI, Joa I, Friis S, Haahr U, Johannessen JO, Larsen TK, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan T (2010) The development of subjective quality of life over the first 2 years in first-episode psychosis. J Nerv Ment Dis 198:864–869PubMedCrossRef Melle I, Røssberg JI, Joa I, Friis S, Haahr U, Johannessen JO, Larsen TK, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan T (2010) The development of subjective quality of life over the first 2 years in first-episode psychosis. J Nerv Ment Dis 198:864–869PubMedCrossRef
28.
Zurück zum Zitat Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976) The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33:766–771PubMed Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976) The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33:766–771PubMed
29.
Zurück zum Zitat Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R (2000) Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand 101:323–329PubMed Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R (2000) Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand 101:323–329PubMed
30.
Zurück zum Zitat Juckel G, Schaub D, Fuchs N, Naumann U, Uhl I, Witthaus H, Hargarter L, Bierhoff HW, Brüne M (2008) Validation of the Personal and Social Performance (PSP) Scale in a German sample of acutely ill patients with schizophrenia. Schizophr Res 104:287–293PubMedCrossRef Juckel G, Schaub D, Fuchs N, Naumann U, Uhl I, Witthaus H, Hargarter L, Bierhoff HW, Brüne M (2008) Validation of the Personal and Social Performance (PSP) Scale in a German sample of acutely ill patients with schizophrenia. Schizophr Res 104:287–293PubMedCrossRef
31.
Zurück zum Zitat Tianmei S, Liang S, Yun’ai S, Chenghua T, Jun Y, Jia C, Xueni L, Qi L, Yantao M, Weihua Z, Hongyan Z (2011) The Chinese version of the Personal and Social Performance Scale (PSP): validity and reliability. Psychiatry Res 185:275–279 Tianmei S, Liang S, Yun’ai S, Chenghua T, Jun Y, Jia C, Xueni L, Qi L, Yantao M, Weihua Z, Hongyan Z (2011) The Chinese version of the Personal and Social Performance Scale (PSP): validity and reliability. Psychiatry Res 185:275–279
32.
Zurück zum Zitat Brissos S, Palhavã F. Marques JG, Carmo AL, Carvalho M, Dias C, Franco JD, Mendes R, Zuzarte P, Carita AI, Molodynski A, Figueira ML. The Portuguese version of the Personal and Social Performance Scale (PSP): reliability, validity, and relationship with cognitive measures in hospitalized and community schizophrenia patients. Submitted to publication in Soc Psychiatry Psychiatr Epidemiol Brissos S, Palhavã F. Marques JG, Carmo AL, Carvalho M, Dias C, Franco JD, Mendes R, Zuzarte P, Carita AI, Molodynski A, Figueira ML. The Portuguese version of the Personal and Social Performance Scale (PSP): reliability, validity, and relationship with cognitive measures in hospitalized and community schizophrenia patients. Submitted to publication in Soc Psychiatry Psychiatr Epidemiol
33.
Zurück zum Zitat Schaub D, Brüne M, Jaspen E, Pajonk FG, Bierhoff HW, Juckel G (2011) The illness and everyday living: close interplay of psychopathological syndromes and psychosocial functioning in chronic schizophrenia. Eur Arch Psychiatry Clin Neurosci 261:85–93 Schaub D, Brüne M, Jaspen E, Pajonk FG, Bierhoff HW, Juckel G (2011) The illness and everyday living: close interplay of psychopathological syndromes and psychosocial functioning in chronic schizophrenia. Eur Arch Psychiatry Clin Neurosci 261:85–93
34.
Zurück zum Zitat Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22–33. (Portuguese version: Guterres T, Levi P, Amorim P, Lisbon, PORTUGAL) Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22–33. (Portuguese version: Guterres T, Levi P, Amorim P, Lisbon, PORTUGAL)
35.
Zurück zum Zitat Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276PubMed Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276PubMed
36.
Zurück zum Zitat Vaz Serra A, Canavarro MC, Simões MR, Pereira M, Gameiro S, Quartilho MJ, Rijo D, Carona C, Paredes T (2006) Estudos Psicométricos do Instrumento de Avaliação da Qualidade de Vida da Organização Mundial de Saúde (WHOQOL-Bref) para Português de Portugal. Psiquiatria Clínica 27:41–49 Vaz Serra A, Canavarro MC, Simões MR, Pereira M, Gameiro S, Quartilho MJ, Rijo D, Carona C, Paredes T (2006) Estudos Psicométricos do Instrumento de Avaliação da Qualidade de Vida da Organização Mundial de Saúde (WHOQOL-Bref) para Português de Portugal. Psiquiatria Clínica 27:41–49
37.
Zurück zum Zitat Group WHOQOL (1998) Development of the World Health Organization WHOQOL–BREF quality of life assessment. Psychol Med 28:551–558CrossRef Group WHOQOL (1998) Development of the World Health Organization WHOQOL–BREF quality of life assessment. Psychol Med 28:551–558CrossRef
38.
Zurück zum Zitat Association AmericanPsychiatric (2000) Diagnostic and statistic manual of mental disorders text revision, 4th edn. American Psychiatric Association, Washington, DC Association AmericanPsychiatric (2000) Diagnostic and statistic manual of mental disorders text revision, 4th edn. American Psychiatric Association, Washington, DC
39.
Zurück zum Zitat Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T (2005) Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 62:975–983PubMedCrossRef Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T (2005) Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 62:975–983PubMedCrossRef
40.
Zurück zum Zitat Bowie CR, Leung WW, Reichenberg A, McClure MM, Patterson TL, Heaton RK, Harvey PD (2008) Predicting schizophrenia patients’ real-world behaviour with specific neuropsychological and functional capacity measures. Biol Psychiatry 63:505–511PubMedCrossRef Bowie CR, Leung WW, Reichenberg A, McClure MM, Patterson TL, Heaton RK, Harvey PD (2008) Predicting schizophrenia patients’ real-world behaviour with specific neuropsychological and functional capacity measures. Biol Psychiatry 63:505–511PubMedCrossRef
41.
Zurück zum Zitat Lipkovich IA, Deberdt W, Csernansky JG, Sabbe B, Keefe RS, Kollack-Walker S (2009) Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy. BMC Psychiatry 14:44CrossRef Lipkovich IA, Deberdt W, Csernansky JG, Sabbe B, Keefe RS, Kollack-Walker S (2009) Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy. BMC Psychiatry 14:44CrossRef
42.
Zurück zum Zitat Leifker FR, Bowie CR, Harvey PD (2009) Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophr Res 115:82–87PubMedCrossRef Leifker FR, Bowie CR, Harvey PD (2009) Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophr Res 115:82–87PubMedCrossRef
43.
Zurück zum Zitat Yen CF, Cheng CP, Huang CF, Ko CH, Yen JY, Chang YP, Chen CS (2009) Relationship between psychosocial adjustment and executive function in patients with bipolar disorder and schizophrenia in remission: the mediating and moderating effects of insight. Bipolar Disord 11:190–197PubMedCrossRef Yen CF, Cheng CP, Huang CF, Ko CH, Yen JY, Chang YP, Chen CS (2009) Relationship between psychosocial adjustment and executive function in patients with bipolar disorder and schizophrenia in remission: the mediating and moderating effects of insight. Bipolar Disord 11:190–197PubMedCrossRef
44.
Zurück zum Zitat Startup M, Jackson MC, Startup S (2010) Insight, social functioning and readmission to hospital in patients with schizophrenia-spectrum disorders: prospective associations. Psychiatry Res 178:17–22PubMedCrossRef Startup M, Jackson MC, Startup S (2010) Insight, social functioning and readmission to hospital in patients with schizophrenia-spectrum disorders: prospective associations. Psychiatry Res 178:17–22PubMedCrossRef
45.
Zurück zum Zitat Sim K, Mahendran R, Siris SG, Heckers S, Chong SA (2004) Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression. Psychiatry Res 129:141–147PubMedCrossRef Sim K, Mahendran R, Siris SG, Heckers S, Chong SA (2004) Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression. Psychiatry Res 129:141–147PubMedCrossRef
46.
Zurück zum Zitat Bengtsson-Tops A, Hansson L (1999) Subjective quality of life in schizophrenic patients living in the community. Relationship to clinical and social characteristics. Eur Psychiatry 14:256–263PubMedCrossRef Bengtsson-Tops A, Hansson L (1999) Subjective quality of life in schizophrenic patients living in the community. Relationship to clinical and social characteristics. Eur Psychiatry 14:256–263PubMedCrossRef
47.
Zurück zum Zitat Parker G, O’Donnell M, Hadzi-Pavlovic D, Proberts M (2002) Assessing outcome in community mental health patients: a comparative analysis of measures. Int J Soc Psychiatry 48:11–19PubMedCrossRef Parker G, O’Donnell M, Hadzi-Pavlovic D, Proberts M (2002) Assessing outcome in community mental health patients: a comparative analysis of measures. Int J Soc Psychiatry 48:11–19PubMedCrossRef
48.
Zurück zum Zitat Chino B, Nemoto T, Fujii C, Mizuno M (2009) Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia. Psychiatry Clin Neurosci 63:521–528PubMedCrossRef Chino B, Nemoto T, Fujii C, Mizuno M (2009) Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia. Psychiatry Clin Neurosci 63:521–528PubMedCrossRef
49.
Zurück zum Zitat Heslegrave RJ, Awad AG, Voruganti LN (1997) The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. J Psychiatry Neurosci 22:235–243PubMed Heslegrave RJ, Awad AG, Voruganti LN (1997) The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. J Psychiatry Neurosci 22:235–243PubMed
50.
Zurück zum Zitat Abel KM, Drake R, Goldstein JM (2010) Sex differences in schizophrenia. Int Rev Psychiatry 22:417–428PubMedCrossRef Abel KM, Drake R, Goldstein JM (2010) Sex differences in schizophrenia. Int Rev Psychiatry 22:417–428PubMedCrossRef
51.
Zurück zum Zitat Kwon JS, Choi JS (2009) Social functioning and quality of life as measures of effectiveness in the treatment of schizophrenia. World Psychiatry 8:35–36PubMed Kwon JS, Choi JS (2009) Social functioning and quality of life as measures of effectiveness in the treatment of schizophrenia. World Psychiatry 8:35–36PubMed
52.
Zurück zum Zitat Awad AG, Voruganti LN, Heslegrave RJ (1997) A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation. Qual Life Res 6:21–26PubMedCrossRef Awad AG, Voruganti LN, Heslegrave RJ (1997) A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation. Qual Life Res 6:21–26PubMedCrossRef
53.
Zurück zum Zitat Awad AG (1997) Quality of life rediscovered: implications for clinical outcome and health economics in schizophrenia. J Psychiatry Neurosci 22:229–230PubMed Awad AG (1997) Quality of life rediscovered: implications for clinical outcome and health economics in schizophrenia. J Psychiatry Neurosci 22:229–230PubMed
54.
Zurück zum Zitat Kulkarni J, de Castella AR, Filia KM, Filia SL, Marston N, Montgomery W, Christova L, Fitzgerald PB (2007) Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: outcomes. Aust N Z J Psychiatry 41:969–979PubMedCrossRef Kulkarni J, de Castella AR, Filia KM, Filia SL, Marston N, Montgomery W, Christova L, Fitzgerald PB (2007) Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: outcomes. Aust N Z J Psychiatry 41:969–979PubMedCrossRef
55.
Zurück zum Zitat Reine G, Bernard D, Lancon C (1998) Depression scales in schizophrenia: a critical review. Encephale 24:530–540PubMed Reine G, Bernard D, Lancon C (1998) Depression scales in schizophrenia: a critical review. Encephale 24:530–540PubMed
56.
Zurück zum Zitat Adrianzén C, Arango-Dávila C, Araujo DM, Ruíz I, Walton RJ, Dossenbach M, Karagianis J (2010) Relative association of treatment-emergent adverse events with quality of life of patients with schizophrenia: post hoc analysis from a 3-year observational study. Hum Psychopharmacol 25:439–447PubMedCrossRef Adrianzén C, Arango-Dávila C, Araujo DM, Ruíz I, Walton RJ, Dossenbach M, Karagianis J (2010) Relative association of treatment-emergent adverse events with quality of life of patients with schizophrenia: post hoc analysis from a 3-year observational study. Hum Psychopharmacol 25:439–447PubMedCrossRef
57.
Zurück zum Zitat Wegener S, Redoblado-Hodge MA, Lucas S, Fitzgerald D, Harris A, Brennan J (2005) Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Aust N Z J Psychiatry 39:487–492PubMedCrossRef Wegener S, Redoblado-Hodge MA, Lucas S, Fitzgerald D, Harris A, Brennan J (2005) Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Aust N Z J Psychiatry 39:487–492PubMedCrossRef
58.
Zurück zum Zitat Yanos PT, Moos RH (2007) Determinants of functioning and well-being among individuals with schizophrenia: an integrated model. Clin Psychol Rev 27:58–77PubMedCrossRef Yanos PT, Moos RH (2007) Determinants of functioning and well-being among individuals with schizophrenia: an integrated model. Clin Psychol Rev 27:58–77PubMedCrossRef
59.
Zurück zum Zitat Eklund M, Hansson L, Bengtsson-Tops A (2004) The influence of temperament and character on functioning and aspects of psychological health among people with schizophrenia. Eur Psychiatry 19:34–41PubMedCrossRef Eklund M, Hansson L, Bengtsson-Tops A (2004) The influence of temperament and character on functioning and aspects of psychological health among people with schizophrenia. Eur Psychiatry 19:34–41PubMedCrossRef
60.
Zurück zum Zitat Sibitz I, Amering M, Unger A, Seyringer ME, Bachmann A, Schrank B, Benesch T, Schulze B, Woppmann A (2011) The impact of the social network, stigma and empowerment on the quality of life in patients with schizophrenia. Eur Psychiatry 26:28–33 Sibitz I, Amering M, Unger A, Seyringer ME, Bachmann A, Schrank B, Benesch T, Schulze B, Woppmann A (2011) The impact of the social network, stigma and empowerment on the quality of life in patients with schizophrenia. Eur Psychiatry 26:28–33
61.
Zurück zum Zitat Staring AB, Van der Gaag M, Van den Berge M, Duivenvoorden HJ, Mulder CL (2009) Stigma moderates the associations of insight with depressed mood, low self-esteem, and low quality of life in patients with schizophrenia spectrum disorders. Schizophr Res 115:363–369PubMedCrossRef Staring AB, Van der Gaag M, Van den Berge M, Duivenvoorden HJ, Mulder CL (2009) Stigma moderates the associations of insight with depressed mood, low self-esteem, and low quality of life in patients with schizophrenia spectrum disorders. Schizophr Res 115:363–369PubMedCrossRef
Metadaten
Titel
Is personal and social functioning associated with subjective quality of life in schizophrenia patients living in the community?
verfasst von
Sofia Brissos
Vicent Balanzá-Martinez
Vasco Videira Dias
Ana Isabel Carita
Maria Luisa Figueira
Publikationsdatum
01.10.2011
Verlag
Springer-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 7/2011
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-011-0200-z

Weitere Artikel der Ausgabe 7/2011

European Archives of Psychiatry and Clinical Neuroscience 7/2011 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.